|By Marketwired .||
|February 25, 2014 02:41 PM EST||
CARY, NC -- (Marketwired) -- 02/25/14 -- Industry Standard Research (ISR) has announced the availability of a new report titled "Forest Labs Clinical Development Profile." This report provides a thorough analysis of Forest Laboratories' R&D pipeline, clinical trial activity, patents, FDA submissions, and includes profiles of Forest's key products.
"In Forest's January 2014 financial conference call they noted that 'Research and Development spending for the current quarter was approximately $220 million as compared to $325 million reported in the third quarter last year, a reported decrease of 33%,'" explained Andrew Schafer, President of ISR.
"We certainly did not see Forest's recent acquisition of Aptalis coming or the more recent offer by Actavis to buy Forest Labs for $25 Billion. However, we did realize that Forest was a company in play," Schafer continued.
ISR's report provides pharmaceutical companies and service providers with a look into Forest's individual drug sales and company financial condition over the past four years, the number, length, and patient enrollment of clinical trials segmented by phase and trial type, and Forest's R&D pipeline with mechanism of action identified. This data will help service providers better understand Forest's clinical pipeline while giving sponsors an idea of how these competing compounds may affect the launch of similar products.
For more information on ISR's "Forest Labs Clinical Development Profile" report, please visit ISR's report page at http://www.isrreports.com/product/forest-labs-clinical-development-profile/.
About Industry Standard Research
Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience, ISR delivers an unmatched level of domain expertise. For more information about our off-the-shelf intelligence and custom research offerings, please visit the company's Web site at www.ISRreports.com, email [email protected], or follow us on Twitter @ISRreports.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2528597
+1 (919) 301-0106
Oct. 1, 2016 11:30 AM EDT Reads: 1,322
Oct. 1, 2016 11:15 AM EDT Reads: 868
Oct. 1, 2016 10:45 AM EDT Reads: 602
Oct. 1, 2016 10:30 AM EDT Reads: 1,724
Oct. 1, 2016 10:30 AM EDT Reads: 710
Oct. 1, 2016 10:00 AM EDT Reads: 519
Oct. 1, 2016 10:00 AM EDT Reads: 3,319
Oct. 1, 2016 10:00 AM EDT Reads: 3,197
Oct. 1, 2016 10:00 AM EDT Reads: 605
Oct. 1, 2016 10:00 AM EDT Reads: 4,672
Oct. 1, 2016 09:45 AM EDT Reads: 834
Oct. 1, 2016 09:45 AM EDT Reads: 2,769
Oct. 1, 2016 09:15 AM EDT Reads: 1,677
Much of the value of DevOps comes from a (renewed) focus on measurement, sharing, and continuous feedback loops. In increasingly complex DevOps workflows and environments, and especially in larger, regulated, or more crystallized organizations, these core concepts become even more critical. In his session at @DevOpsSummit at 18th Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, showed how, by focusing on 'metrics that matter,' you can provide objective, transparent, and meaningful f...
Oct. 1, 2016 09:00 AM EDT Reads: 2,944